Lifeward Ltd. announced it entered into a secured promissory note with Oramed Pharmaceuticals on February 12, 2026, for $525,000, which may increase to $1.5 million, with an interest rate of 24% per annum. This financing is secured by the company's cash and has specific conditions for repayment and events of default.